Rousselot B.V.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Nov 2035
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Apr 24, 2027The maintenance fee for Low cross-linking gelatine (US 11,795,489) comes due Apr 24, 2027. Unpaid by Oct 25, 2027, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 9 of 9
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,155,805 | Gelatin purification In force · From the USPTO record | In force | From the USPTO record | |
| US 11,110,147 | Collagen Hydrolysates as a Beneficial Prebiotic and Their Effect on Joint Inflammation and Osteoarthritis In force · High confidence | In force | High confidence | |
| US 11,490,634 | Method and composition for the preparation of gelatin based gummy candies In force · From the USPTO record | In force | From the USPTO record | |
| US 11,795,489 | Low cross-linking gelatine In force · From the USPTO record | In force | From the USPTO record | |
| US 12,371,569 | Low Endotoxin Gelatin-(METH)acryloyl In force · High confidence | In force | High confidence | |
| US 12,589,131 | Use of Collagen Hydrolysate in Prevention And/Or Treatment of Food Craving In force · High confidence | In force | High confidence | |
| US 12,440,533 | Collagen Hydrolysate Composition for Reducing Joint Pain After Exercise In force · High confidence | In force | High confidence | |
| US 12,636,339 | Hydrolyzed Collagen for Use in Reducing Blood Glucose In force · High confidence | In force | High confidence | |
| US 12,226,459 | Collagen Hydrolysate for Use in Prevention And/Or Treatment of Post Intensive Care Syndrome (PICS) In force · Medium confidence | In force | Medium confidence |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
4 pending · 2 abandoned · 3 no status recorded